Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Broadwell Pharmaceutical Co., Ltd. Welcome you!

Service hotline:+86-431-85639055

Company Profile

President Speech

COMPANY CULTURE

development path

Brand Honors

TEAM MANAGEMENT

COMPANY

PROFILE

Jilin Province Great Great Pharmaceutical Co. LTD

Boda Weiye is a new type of CDMO enterprise that focuses on the research and development, production, and production of chemical drugs and biological drugs.
Based on the strategic layout of "one production base, two R&D platforms", create an enterprise innovation chain and industrial chain;
The company takes R&D innovation as its core driving force, and its R&D direction is small molecule chemical drugs and biotechnology. It builds an enterprise product pipeline through the “integration of raw materials and preparations”, “small molecule API innovation technology platform”, and “combination of imitation and innovation”. "R&D generation, production generation, reserve generation, optimization generation" form to obtain medium and long-term competitiveness;
The company has established a professional promotion team, and established long-term cooperation with more than 100 GSP companies and CSO companies across the country to achieve drug promotion and sales.

  • 2010

    years

    Great Greatness was formally founded

  • 9900

    Ten thousand yuan

    Registered capital

  • 30+

    a

    New drugs in development

PRODUCT

CENTER

Jilin Province Great Great Pharmaceutical Co. LTD
imgboxbg

Broad Great Pharma

Maintain the health of the people


Chemical API

Polaprezine

Polaprezine is a complex compound formed by zinc and L-carnosine. Zinc is an ideal carrier for L-carnosine. The two produce a significant synergy.

Linezolid Injection

Linezolid glucose injection is a synthetic oxazolidinone antibiotic. It is a bacterial protein synthesis inhibitor. It acts on the 50S ribosomal subunit of bacteria to prevent the formation of 70S initial complexes, thereby inhibiting the synthesis of bacterial protein. It is used to treat infections caused by gram-positive (G) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by MRSA, community-acquired pneumonia (CAP), complex skin or skin and soft tissue infections (SSTI), and resistant Vancomycin enterococcus infection, etc., and its safety is good, and it can be used from newborn babies to elderly patients, and its clinical application range is relatively wide. Linezolid glucose injection has more clinical application data and guideline recommendations, and is highly recognized by physicians.

Clopidogrel

Clopidogrel, as an ADP receptor antagonist, prevents ADP from binding to ADP receptors on platelets and prevents glycoprotein IIb/IIIa receptors from binding to fibrinogen, thereby inhibiting platelet aggregation. It is used to prevent and treat heart, brain and other arterial circulatory disorders caused by high platelet aggregation, such as recent strokes, myocardial infarction and confirmed peripheral arterial diseases.

Fasudil

Fasudil, as the first Rho kinase inhibitor to be used in clinical practice, can inhibit the final stage of vascular smooth muscle contraction with dual targets, and target the movement of inflammatory cytoskeleton proteins to prevent and treat vasospasm. Interventional partner for the treatment of cerebral vasospasm. The treatment is targeted, safe, and does not affect systemic blood pressure.

Sodium Ferulate

Sodium ferulate is the sodium salt of ferulic acid, which is the main component of angelica sinensis, a traditional Chinese medicine for promoting blood circulation to remove blood stasis. The sodium ferulate injection compounded by using modern technology, not only retains the effect of promoting blood circulation to remove blood stasis of angelica sinensis, but gives a new connotation. The endothelin receptor antagonists are oxidation resistant, which can clear free radicals, and prevent platelet aggregation, with anti-inflammatory and immune adjustments, increasing blood creation function.

R&D

INNOVATION

Jilin Province Great Great Pharmaceutical Co. LTD
Innovation system
MORE 白箭头 黑箭头
Research and development ability
MORE 白箭头 黑箭头
In research products
MORE 白箭头 黑箭头
The scientific research cooperation
MORE 白箭头 黑箭头
Production management system
MORE 白箭头 黑箭头
Quality management system
MORE 白箭头 黑箭头

STYLE

CORPORATE

Jilin Province Great Great Pharmaceutical Co. LTD

HEALTH

SCIENCE

Jilin Province Great Great Pharmaceutical Co. LTD
There is currently no information to display
Please add data record on website background.

NEWS

CENTER

Jilin Province Great Great Pharmaceutical Co. LTD
Data collation...
Details 白箭头 黑箭头
Jilin Province Great Great Pharmaceutical Co. LTD

Service hotline

+86-431-81158731

CONTACT US

Jilin Broadwell Pharmaceutical Co., Ltd.

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Liaoyuan Production Base: No. 158 Fortune Road, Liaoyuan Economic Development Zone, Jilin Province

Tel:+86 400-688-0199

Changchun R&D Center: No. 3786 Juye Street, Jingyue Development Zone, Changchun City, Jilin Province
Tel:+86-431-81158731(Marketing center)

Tel:+86-431-81158756(Research and development center)

Beijing Office: Room 901, Building F, Kaixuan City, 170 Beiyuan Road, Chaoyang District, Beijing
Tel:+86-10-58236233

Medication consultation, feedback on medication adverse reaction, and user complaint telephone:400-688-0199

NO PUBLIC

Jilin Province Great Great Pharmaceutical Co. LTD

Scan and follow the official official account

Copyright © Jilin Broadwell Pharmaceutical Co., Ltd.        吉ICP备20002630号

Website construction:300.cn Changchun   management     

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Great Great Pharmaceutical Co. LTD